NCT05788159
An Open Label, Balanced, Randomized, Two-Treatment, Two-Period, Two-Sequence, Two-way Crossover, Oralcomparative Pharmacokinetic(PK)Study of Lacosamide Extended-Release Tablets , Adult, Human Subjects Under Fasting Conditions.
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 1, 2023
Completion: Jul 31, 2023